CLASS II ONGOING Device recall · Reported 28 Dec 2022 · FDA Enforcement Report

Centricity Pacs-iw with Universal Viewer recalled by GE Medical Systems

GE Medical Systems is recalling Centricity Pacs-iw with Universal Viewer, distributed nationwide in the US. The recall was initiated on 28 Oct 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesInstalled Product ID: YP3150-Centricity Universal Viewer-01639018
Quantity recalled1 unit

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0721-2023
FDA event ID
91159
Recalling firm
GE Medical Systems, Waukesha, WI
Classification
Class II
Status
Ongoing
Recall initiated
28 Oct 2022
FDA classified
16 Dec 2022
Reported
28 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

28 Oct 2022Recall initiated by company
16 Dec 2022Classified by FDA+49 days
28 Dec 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is the potential that after installation of the IAS tool, some studies can remain hidden without user notification. Access to those hidden studies requires GE Healthcare assistance, which can result in a delay in reading the study.

Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.

Product as listed by the FDA

Centricity PACS-IW with Universal Viewer version 5.0. Used to display medical images (Including mammograms) and data from various imaging sources.

Where it was distributed

Nationwide distribution to CA, CO, DE, FL, IA, IL, MA, MI, MN, MO, MS, MT, ND, NJ, NY, OK, OR, SD, TX, WI, WV, WY. International distribution to Austria, Brazil, France, Germany, Ghana, Ireland, Italy, Kuwait, Poland, Saudi Arabia, South Africa, Spain, Switzerland, United Kingdom.

Nationwide CaliforniaColoradoDelawareFloridaIowaIllinoisMassachusettsMichiganMinnesotaMissouriMississippiMontanaNorth DakotaNew JerseyNew YorkOklahomaOregonSouth DakotaTexasWisconsin

Questions about this recall

Why was it recalled?

There is the potential that after installation of the IAS tool, some studies can remain hidden without user notification. Access to those hidden studies requires GE Healthcare assistance, which can result in a delay in reading the study.

Which lots are affected?

Installed Product ID: YP3150-Centricity Universal Viewer-01639018

Where was it sold?

Nationwide distribution to CA, CO, DE, FL, IA, IL, MA, MI, MN, MO, MS, MT, ND, NJ, NY, OK, OR, SD, TX, WI, WV, WY. International distribution to Austria, Brazil, France, Germany, Ghana, Ireland, Italy, Kuwait, Poland, Saudi Arabia, South Africa, Spain, Switzerland, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 91159

This product is part of a recall event; the main page for the event is Centricity Universal Viewer recalled by GE Medical Systems.

ReportedClassRecallCompanyReasonWhere
CLASS IICentricity Universal Viewer recalled by GE Medical SystemsGE Medical SystemsHidden Drug IngredientsNationwide

More recalls from GE Medical Systems

All 160

Other Imaging Equipment recalls

All 2,347